There was a higher relative frequency of the HLA DRB1*1501 positive-CCSVI positive combination compared to the HLA DRB1*1501 negative-CCSVI negative combination in progressive MS but this was not significant. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.